These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23668973)

  • 21. Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning.
    Gould F; McGuire LS; Durand D; Sabbag S; Larrauri C; Patterson TL; Twamley EW; Harvey PD
    Neuropsychology; 2015 Sep; 29(5):675-82. PubMed ID: 25643212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of demographic factors on functional capacity and everyday functional outcomes in schizophrenia.
    Gould F; Bowie CR; Harvey PD
    J Clin Exp Neuropsychol; 2012; 34(5):467-75. PubMed ID: 22272559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of self-report and performance-based measures of everyday functioning in individuals with schizophrenia: implications for measure selection.
    Elliott CS; Fiszdon JM
    Cogn Neuropsychiatry; 2014; 19(6):485-94. PubMed ID: 24901357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
    Lipkovich IA; Deberdt W; Csernansky JG; Sabbe B; Keefe RS; Kollack-Walker S
    BMC Psychiatry; 2009 Jul; 9():44. PubMed ID: 19602273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?
    Harvey PD; Bellack AS
    Schizophr Bull; 2009 Mar; 35(2):300-6. PubMed ID: 19126634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia.
    Schaub D; Brüne M; Jaspen E; Pajonk FG; Bierhoff HW; Juckel G
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):85-93. PubMed ID: 20652295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.
    Granholm E; Holden JL; Sommerfeld D; Rufener C; Perivoliotis D; Mueser K; Aarons GA
    Trials; 2015 Sep; 16():438. PubMed ID: 26424639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional capacity: a new framework for the assessment of everyday functioning in schizophrenia.
    Mantovani LM; Teixeira AL; Salgado JV
    Braz J Psychiatry; 2015; 37(3):249-55. PubMed ID: 26376057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.
    Wittorf A; Wiedemann G; Buchkremer G; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2008 Feb; 258(1):48-58. PubMed ID: 17990052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised, observer-blinded multi-centre clinical trial.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Forchhammer HB; Melau M; Gluud C; Nordentoft M
    Trials; 2011 Feb; 12():35. PubMed ID: 21306612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social/communication skills, cognition, and vocational functioning in schizophrenia.
    Dickinson D; Bellack AS; Gold JM
    Schizophr Bull; 2007 Sep; 33(5):1213-20. PubMed ID: 17164469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functioning in patients with schizophrenia: A multicentre study evaluating the clinical perspective.
    Barrios M; Gómez-Benito J; Pino O; Rojo E; Guilera G
    Psychiatry Res; 2018 Dec; 270():1092-1098. PubMed ID: 29907336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.
    Bowie CR; Reichenberg A; Patterson TL; Heaton RK; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):418-25. PubMed ID: 16513862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia.
    Revheim N; Schechter I; Kim D; Silipo G; Allingham B; Butler P; Javitt DC
    Schizophr Res; 2006 Apr; 83(2-3):237-45. PubMed ID: 16443347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and symptomatic predictors of functional disability in schizophrenia.
    Shamsi S; Lau A; Lencz T; Burdick KE; DeRosse P; Brenner R; Lindenmayer JP; Malhotra AK
    Schizophr Res; 2011 Mar; 126(1-3):257-64. PubMed ID: 20828991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.